4DMedical is trading 7.34% up at A$3.80 on September 17, 2026, amid a strong broader-market recovery, though no announcement explicitly links its Life Sciences Virtual Investor Forum presentation to the share move.
- Major U.S. indices gained more than 1% intraday as yields and oil prices eased.
- 4DMedical presented its lung-imaging growth strategy, highlighting CT:VQ, reimbursement progress, cash resources, and international expansion plans.